|
Design Feature:
|
(1) Quadrilaterals with dark surfaces or parts of surfaces
(2) Rhombs or squares standing on one of the corners thereof
(3) One quadrilateral
(4) Letters presenting a special form of writing
(5) One letter
(6) Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.
|
|
Description:
|
(1) - Pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of mental conditions, illnesses and disorders; drugs for the treatment of mental conditions, illnesses and disorders; psychedelic pharmaceuticals; psychedelic-based medicines; neurogenerative drugs; serotonin receptor agonists and antagonist drugs; abuse deterrent products; pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms; therapies for the treatment of mental conditions, illnesses and disorders.
(2) - Downloadable applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; Downloadable applications for use in therapy of cognitive states; Computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; Computer software applications for use in therapy of cognitive states; medical systems for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical systems for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for stimulating nerves.
(3) - Electroencephalogram (EEG) devices; medical devices for monitoring, sensing, measuring and training brain and neural activity; medical devices for use in therapy of cognitive states; medical devices for stimulating nerves; device used for treating of mental health disorders non-invasively; combination of a device used for treating mental health disorders non-invasively plus pharmaceutical preparations.
(4) - Operation of a pharmaceutical business, namely, distribution and sale of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; commercialization of pharmaceuticals, drugs, therapies and health care products namely, selling, distributing, developing marketing strategies in the field of pharmaceuticals, drugs, and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; operation of a pharmaceutical business, namely, distribution and sale of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders; commercialization of pharmaceuticals, drugs, and health care products namely, selling, distributing, developing marketing strategies in the field of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders.
(5) - Production of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; production of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders.
(6) - Pharmaceutical research and development; drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery; pharmacology; psychedelic pharmaceutical company; research in the field of mental health conditions, illnesses and disorders; neuropsychiatric drug discovery including pre-clinical and clinical drug development; drug development and discovery including new chemical entities, neurogenerative drugs, seretonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms.
(7) - Licensing of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; licensing of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders.
|